ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) was the recipient of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 11,200 shares, a growth of 154.5% from the January 31st total of 4,400 shares. Based on an average daily volume of 10,100 shares, the short-interest ratio is presently 1.1 days.

ProShares Ultra Nasdaq Biotechnology Trading Up 2.6 %

NASDAQ BIB opened at $55.00 on Friday. The company has a 50 day moving average of $53.54 and a 200-day moving average of $59.10. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $47.19 and a 1-year high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The business also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were given a dividend of $0.3964 per share. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date was Monday, December 23rd.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Crowley Wealth Management Inc. acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter valued at $51,000. Jane Street Group LLC boosted its stake in ProShares Ultra Nasdaq Biotechnology by 8.4% in the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock valued at $306,000 after buying an additional 374 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in ProShares Ultra Nasdaq Biotechnology by 31.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,326 shares of the exchange traded fund’s stock valued at $270,000 after acquiring an additional 1,266 shares during the last quarter.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

See Also

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.